Glenmark's current portfolio consists of 175 products authorized for distribution in the
About
Contact:
Udaykumar Murthy DGM
Corporate Communications
T: +91 9960377617
E: corpcomm@glenmarkpharma.com
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,206 INR | +1.00% |
|
+2.54% | +41.24% |
May. 30 | Transcript : Glenmark Pharmaceuticals Limited - Analyst/Investor Day | |
May. 29 | Assertio Therapeutics Names Brendan O'Grady as Chief Executive | MT |
Glenmark's current portfolio consists of 175 products authorized for distribution in the
About
Contact:
Udaykumar Murthy DGM
Corporate Communications
T: +91 9960377617
E: corpcomm@glenmarkpharma.com
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+41.24% | 4.04B | |
+20.14% | 43.3B | |
+25.07% | 22.22B | |
+16.89% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-10.97% | 6.71B | |
-8.87% | 5.73B | |
+12.71% | 5.5B |